Impax Laboratories Inc's generic version of the antibiotic drug Adoxa won approval from the Food and Drug Administration.
Hayward-based Impax (NASDAQ: IPXL) said it is preparing to launch its 150-milligram version of the drug, used to pneumonia, urinary tract infections and other bacterial infections, but didn’t offer further details.
No comments:
Post a Comment